1887
Preview this article:
Zoom in
Zoomout

Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease, Page 1 of 1

| /docserver/preview/fulltext/jmm/59/2/141-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.017541-0
2010-02-01
2020-07-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/2/141.html?itemId=/content/journal/jmm/10.1099/jmm.0.017541-0&mimeType=html&fmt=ahah

References

  1. Bajka B. H., Clarke J. M., Cobiac L., Topping D. L. 2008; Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats. Carcinogenesis 29:2169–2174 [CrossRef]
    [Google Scholar]
  2. Breuer R. I., Soergel K. H., Lashner B. A., Christ M. L., Hanauer S. B., Vanagunas A., Harig J. M., Keshavarzian A., Robinson M. other authors 1997; Short-chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomized, placebo-controlled trial. Gut 40:485–491 [CrossRef]
    [Google Scholar]
  3. Cohen M. L. 2000; Changing patterns of infectious disease. Nature 406:762–767 [CrossRef]
    [Google Scholar]
  4. Danese S., Fiocchi C. 2006; Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 12:4807–4812
    [Google Scholar]
  5. Eeckhaut V., Flahou B., Romero C., Van Der Heyden S., Pasmans F., Haesebrouck F., Ducatelle R., Van Immerseel F. 2009; The anaerobic butyrate-producing strain Butyricicoccus pullicaecorum decreases colonic inflammation and ulceration in a TNBS-induced colitis rat model. In 5th Probiotics, Prebiotics and New Foods Congress. Rome, Italy http://www.probiotics-prebiotics-newfood.org/pdf/5th_Probiotics_Prebiotics_Newfood.pdf
    [Google Scholar]
  6. Flint H. J., Duncan S. H., Scott K. P., Louis P. 2007; Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 9:1101–1111 [CrossRef]
    [Google Scholar]
  7. Geier M. S., Butler R. N., Howarth G. S. 2007; Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 115:1–11 [CrossRef]
    [Google Scholar]
  8. Gueimonde M., Ouwehand A., Huhtinen H., Salminen E., Salminen S. 2007; Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 13:3985–3989 [CrossRef]
    [Google Scholar]
  9. Hamer H. M., Jonkers D., Venema K., Vanhoutvin S., Troost F. J., Brummer R. J. 2008; Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104–119
    [Google Scholar]
  10. Hedin C., Whelan K., Lindsay J. O. 2007; Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 66:307–315 [CrossRef]
    [Google Scholar]
  11. Louis P., Flint H. J. 2009; Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1–8 [CrossRef]
    [Google Scholar]
  12. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I. C., Nicholls R. J., Gionchetti P., Campieri M., Kamm M. A. 2004; Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:108–114 [CrossRef]
    [Google Scholar]
  13. Ouyang Q., Tandon R., Goh K. L., Ooi C. J., Ogata H., Fiocchi C. 2005; The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 21:408–413
    [Google Scholar]
  14. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L. G., Gratadoux J. J., Blugeon S., Bridonneau C., Furet J. P. other authors 2008; Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731–16736 [CrossRef]
    [Google Scholar]
  15. Sokol H., Seksik P., Furet J. P., Firmesee O., Nion-Larmurier I., Beaugerie L., Cosnes J., Corthier G., Marteau P., Doré J. 2009; Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15:1183–1189 [CrossRef]
    [Google Scholar]
  16. Srinivas S. R., Prasad P. D., Umapathy N. S., Ganapathy V., Shekhawat P. S. 2007; Transport of butyryl-l-carnitine, a potential prodrug, via the carnitine transporter OCT2 and the amino acid transporter ATB0,+ . Am J Physiol Gastrointest Liver Physiol 293:G1046–G1053 [CrossRef]
    [Google Scholar]
  17. Takaishi H., Matsuki T., Nakazawa A., Takada T., Kado S., Asahara T., Kamada N., Sakuraba A., Yajima T. other authors 2008; Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 298:463–472 [CrossRef]
    [Google Scholar]
  18. Thibault R., Blachier F., Darcy-Vrillon B., De Coppet P., Bourreille A., Segain J. P. 2010; Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis 16: (in press)
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.017541-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error